Skip to main content
. Author manuscript; available in PMC: 2010 Mar 2.
Published in final edited form as: Arch Dermatol. 2009 Mar;145(3):255–260. doi: 10.1001/archdermatol.2008.594

Table 2.

CLASI, modified Skindex-29, and SLEDAI in the CLE patients recruited at the University of Pennsylvania

Type of LE skin manifestations ACLE SCLE CCLE
CLASI Activity (mean+/-SEM; range) 6.4+/-3.3; 0-19 11.1+/-2.5; 0-41 7.5+/-1; 0-32
CLASI Damage (mean+/-SEM; range) 5.1+/-2; 0-11 1.6+/-0.9; 0-17 10.2+/-1.2; 0-40
Modified Skindex-29 (mean+/-SEM; range) 76.3+/-12.1; 43-120 79.4+/-6.9; 33-137 82.7+/-3.3; 34-142
SLEDAI (mean+/-SEM; range) 4.3+/-1.5; 0-10 2.2+/-0.8; 0-10 1.7+/-0.3; 0-11